Objectives: There are limited data on the usage of commercially bought self-tests for HIV and other sexually transmitted infections (STIs). Therefore, we studied HIV/STI self-test usage and its determinants among the general population and sexual risk groups between 2007 and 2015 in Amsterdam, the Netherlands.
Setting: Data were collected in four different studies among the general population (S12) and sexual risk groups (S34).
Participants: S1Amsterdam residents participating in representative population-based surveys (2008 and 2012; n=6044) drawn from the municipality register; S2Participants of a population-based study stratified by ethnicity drawn from the municipality register of Amsterdam (2011-2015; n=17 603); S3Men having sex with men (MSM) participating in an HIV observational cohort study (2008 and 2013; n=597) and S4STI clinic clients participating in a cross-sectional survey (2007-2012; n=5655).
Primary And Secondary Outcome Measures: Prevalence of HIV/STI self-test usage and its determinants.
Results: The prevalence of HIV/STI self-test usage in the preceding 6-12 months varied between 1% and 2% across studies. Chlamydia self-tests were most commonly used, except among MSM in S3. Chlamydia and syphilis self-test usage increased over time among the representative sample of Amsterdam residents (S1) and chlamydia self-test usage increased over time among STI clinic clients (S4). Self-test usage was associated with African Surinamese or Ghanaian ethnic origin (S2), being woman or MSM (S1 and 4) and having had a higher number of sexual partners (S1-2). Among those in the general population who tested for HIV/STI in the preceding 12 months, 5-9% used a self-test.
Conclusions: Despite low HIV/STI self-test usage, we observed increases over time in chlamydia and syphilis self-test usage. Furthermore, self-test usage was higher among high-risk individuals in the general population. It is important to continue monitoring self-test usage and informing the public about the unknown quality of available self-tests in the Netherlands and about the pros and cons of self-testing.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623511 | PMC |
| http://dx.doi.org/10.1136/bmjopen-2017-016609 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Drivers of HIV self-test kit among Tanzanian men aged 15-49: findings from the 2022 TDHS-MIS cross-sectional study.
AIDS Res Ther
January 2025
Department of Mathematics, Physics and Informatics, Mkwawa University College of Education, Iringa, Tanzania.
Introduction: The introduction of the HIV self-test kit in the early 2000s was a major breakthrough in combating HIV. This study determines the social demographic and sexual behaviour driving the use of HIV self-test kits.
Method: The study used secondary data obtained from Tanzania DHS-MIS 2022.
Exploring HIV Self-Testing: Barriers and Facilitators Among Undergraduate Students in Nairobi, Kenya.
Ann Fam Med
November 2024
Kenya Human Resource for Health Advisory Council (KHHRAC), Nairobi, Kenya.
Purpose: Infection with HIV remains a global health challenge, with >36.9 million individuals living with HIV in 2017. Despite efforts to increase HIV testing and treatment, traditional services have not effectively reached marginalized communities.
View Article and Find Full Text PDFAcceptability and validity of HPV self-sampling for cervical cancer screening among women living in different ecological settings in India.
Int J Cancer
October 2024
Department of Microbiology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
India records one fifth of global cervical cancer burden. Unlike human papillomavirus (HPV) self-sampling, other screening methods may cause discomfort and embarrassment. This study aimed to investigate attitudes, acceptability, barriers, predictors, effective modality of instructions, and validity of HPV self-sampling among Indian women residing in varied settings and different literacy levels.
View Article and Find Full Text PDFArticle Synopsis
- The study assessed the acceptability and usability of HIV self-testing (HIVST) kits in India, finding that 97% of eligible participants accepted the kits and 95% found them easy to use and interpret.
- Participants largely preferred HIVST for future testing, with 88% indicating interest, and a significant portion (69%) willing to pay for the kits, although most preferred to pay less than $1.20.
- Out of those who tested positive using HIVST, 89% were linked to confirmatory testing, resulting in a high rate of HIV positive confirmations and successful initiation of antiretroviral therapy (ART).
Double testing with lateral flow antigen test devices for COVID-19: does a second test in quick succession add value?
J Virol Methods
September 2024
UK Health Security Agency, London, UK; William Harvey Research Institute, Queen Mary University of London, London, UK. Electronic address:
Background/objectives: We investigated if performing two lateral flow device (LFD) tests, LFD2 immediately after LFD1, could improve diagnostic sensitivity or specificity for detecting severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) antigen.
Study Design: Individuals aged ≥16 years attending UK community testing sites (February-May 2021) performed two successive LFD tests and provided a nose-and-throat sample for a polymerase chain reaction (PCR) test. Using the PCR result as the reference diagnosis, we assessed whether improvements could be achieved in sensitivity (by counting a positive result in either LFD as a positive overall test result) or specificity (by using LFD2 as confirmatory test).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!